IL-7R positive cells constituted 0.01% (range, 0.008–0.020) of normal PBMCs and 22.1% (range, 1.100–45.200) of PBMCs from pancreatic cancer patients. This evidence concerns the gene IL7R and pancreatic neoplasm.